About SurgAR
SurgAR is a Healthcare company based in Clermont-ferrand (France) founded in 2019. Augmented reality software is developed for laparoscopic surgery applications. It operates in the Healthcare and Technology sectors. SurgAR has raised $14.39 million across 5 funding rounds from investors including BNP Paribas, Crédit Agricole and Banque Populaire. Its chief executive, as recorded, is Nicolas Bourdel. SurgAR offers products and services including AR Software. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include eCential Robotics, Biomodex and inHEART; 3 of its 3 listed competitors have raised funding.
Company details
SurgAR was founded in 2019 in Clermont-Ferrand, France, and operates within the medical technology sector. Augmented reality software is provided for laparoscopic surgery, with features that enable automatic detection of tumors for resection. Critical anatomical structures are located and highlighted automatically. Resection margins are visualized on the organs external surface, allowing incision points to be identified by surgeons.
- Headquarters Clermont-ferrand, France
- SectorsHealthcareTechnology
- Website surgar-surgery.com
- Social LinkedIn
- Legal Name Surgar
- Total Equity Funding$14.39M (USD)
in 5 rounds
- Latest Funding Round$12.29M (USD), Series A
Sep 2024
- InvestorsBNP Paribas
& 13 more
Products & Services of SurgAR
SurgAR offers a comprehensive portfolio of products and services, including AR Software.
Provides real-time AR overlays for improved surgical visualization.
Funding Insights of SurgAR
SurgAR has successfully raised a total of $14.39M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $12.29 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.39M
- Total Rounds 5
- Last Round Series A — $12.29M
- Investors Count 14
All 5 funding rounds of SurgAR with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $12.29M | Series A | – | Mutuelles Impact | |
| Jan 2024 | Seed | – | – | ||
| Jan 2021 | $873,606 | Grant | – | – | |
| Oct 2020 | $2.1M | Seed | – | Kreaxi, Sofimac Investment Managers | – |
| Jun 2020 | Grant | – | – |
14 investors in total: 13 institutional and 1 angel.
Investors in SurgAR
SurgAR has secured backing from 14 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include BNP Paribas, Crédit Agricole and Banque Populaire.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Mutuelles Impact is operated as an impact investment fund focused on health and social sectors. | mutuellesimpact.fr | Strasbourg, France | ||
UI Investissement is engaged in private equity and investment services. | ui-investissement.com | Paris, France | ||
Kreaxi is engaged in equity financing for innovative startups. | kreaxi.com | Limonest, France | ||
| sofimac-im.com | ||||
Healthcare startups are accelerated and incubated through specialized programs. | 2015 | eithealth.eu | Munich, Germany | |
| xange.vc | ||||
Offers insurance, savings, and retirement services for individuals, enterprises, and independents. | 1981 | malakoffhumanis.com | Paris, France | |
Corporate consultancy, advisory, and funding services are provided to businesses. | 2012 | bpifrance.com | Maisons Alfort, France | |
Banking & financial service provider | 1848 | group.bnpparibas | Paris, France | |
Commercial banking services are provided across France by Credit Agricole. | 1988 | credit-agricole.fr | Paris, France |
Investor details for SurgAR
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SurgAR
1 people are tracked at SurgAR (1 in leadership).
| Name | Role | Group |
|---|---|---|
Nicolas Bourdel | CEO | Leadership |
Complete people profiles for SurgAR
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SurgAR
3 dated milestones of SurgAR across 5 years, from founding to its latest funding, stage changes and deals.
- Founded SurgAR is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $12.3M.
Competitors of SurgAR
SurgAR has 3 listed competitors in our database, 3 of them funded. They include eCential Robotics, Biomodex and inHEART.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ecential-robotics.com | 2009 | Gieres, France | $133.97M | Robotic surgery platform for bone procedures is developed. | ||
| biomodex.com | 2014 | Paris, France | $18.6M | 3D printed surgical simulators for medical education and patient-specific preoperative planning | ||
| inheartmedical.com | 2017 | Pessac, France | $15.16M | AI-based 3D cardiac models are developed for therapeutic planning. |
Detailed competitors of SurgAR
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SurgAR
SurgAR was founded in 2019 and raised its 1st funding round 1 year after it was founded.
SurgAR is headquartered in Clermont-ferrand, France. It is registered at Clermont-ferrand, Auvergne-rhone-alpes, France.
Nicolas Bourdel is the CEO of SurgAR, as recorded in our data.
SurgAR is a funded company, having raised a total of $14.39M across 5 funding rounds to date.
SurgAR was founded in 2019 in Clermont-Ferrand, France, and operates within the medical technology sector. Augmented reality software is provided for laparoscopic surgery, with features that enable automatic detection of tumors for resection. Critical anatomical structures are located and highlighted automatically. Resection margins are visualized on the organs external surface, allowing incision points to be identified by surgeons.
SurgAR's top competitors include eCential Robotics, Biomodex and inHEART.
SurgAR offers AR Software.
SurgAR has 14 investors. Key investors include BNP Paribas, Crédit Agricole, Banque Populaire, EIT Health, and Bpifrance.
SurgAR operates through Surgar.